Belgium · Delayed Price · Currency is EUR ageas Earnings Call Transcripts
Fiscal Year 2025
-
Strong growth in both life and non-life segments drove net operating results above guidance, with upgraded financial targets and robust solvency. Strategic acquisitions and a shift in business mix, especially in Asia, further strengthened performance and outlook.
-
The group will acquire full ownership of its core Belgian insurance entity, boosting strategic flexibility, cash flow, and market leadership. The deal is capital efficient, solvency-neutral, and supported by a renewed long-term partnership with BNP Paribas.
-
Strong H1 2025 results with 4% inflow growth, net operating result of EUR 734 million, and upgraded full-year guidance to EUR 1.3–1.35 billion. Cash upstream and shareholder targets were raised, with robust segment performance and continued strategic progress.
Fiscal Year 2024
-
Delivered strong 2024 results with 10% inflow growth, record capital generation, and robust segment performance. Proposed an 8% higher dividend and guided for continued growth in 2025, while managing uncertainties in Asia and CatNat exposure.
-
Elevate27, the new three-year strategy, targets 6%-8% annual EPS growth, over €2.2 billion in holding free cash flow, and more than €1.9 billion in shareholder remuneration, focusing on profitable growth in aging and SME segments, operational excellence, and digital transformation, with sustainability and AI as key enablers.
-
Record H1 inflows and strong operational results drove a net operating result of EUR 613 million, with robust capital generation and improved combined ratios across segments. A EUR 200 million share buyback and interim dividend were announced, supported by a strong solvency position.